MedTrace Logo

CAPTURE 2 Post-Marketing Registry

NCT00302237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6426

Last updated 2012-12-13

No results posted yet for this study

Summary

The purposes of the registry are: 1) To provide an ongoing post-market surveillance mechanism to document clinical outcomes. 2) To provide additional information that the RX ACCULINK™ and RX ACCUNET™ can be used safely by a wide range of physicians under commercial use conditions. 3) To evaluate the adequacy of Abbott Vascular's physician training program.

Conditions

  • Carotid Artery Disease

Interventions

DEVICE

RX ACCULINK, RX ACCUNET Embolic Protection System

1\) To provide an ongoing post-market surveillance mechanism to document clinical outcomes. 2) To provide additional information that the RX ACCULINK™ and RX ACCUNET™ can be used safely by a wide range of physicians under commercial use conditions. 3) To evaluate the adequacy of Abbott Vascular's physician training program.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • William Gray, M.D. · Executive Committee Member

  • Jaysinghe Yadav, M.D. · Executive Committee Member

  • Richard Atkinson, M.D. · Executive Committee Member

  • Ronald Fairman, M.D. · Executive Committee

  • Mark Wholey, M.D. · Executive Committee Member

  • Rod Raabe, M.D. · Executive Committee Member

  • Richard Green, M.D. · Executive Committee Member

  • Nick Hopkins, M.D. · Executive Committee Member

  • Stan Barnwell, M.D. · Executive Committee Member

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-03-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00302237 on ClinicalTrials.gov